1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Actelion

Anonymous board for Actelion


Sort By:
Title
Replies Views
Last Message ↓
  1. Anonymous
    Replies:
    0
    Views:
    2,216
  2. Anonymous
    Replies:
    5
    Views:
    3,368
  3. Anonymous
    Replies:
    4
    Views:
    2,747
  4. Anonymous
    Replies:
    2
    Views:
    2,035
  5. Anonymous
    Replies:
    17
    Views:
    4,964
  6. Anonymous
    Replies:
    20
    Views:
    8,329
  7. Anonymous
    Replies:
    6
    Views:
    3,686
  8. Anonymous
    Replies:
    18
    Views:
    4,167
  9. Anonymous
    Replies:
    32
    Views:
    7,643
  10. Anonymous
    Replies:
    17
    Views:
    6,500
  11. Anonymous
    Replies:
    2
    Views:
    3,289
  12. Anonymous
    Replies:
    12
    Views:
    4,577
  13. Anonymous
    Replies:
    3
    Views:
    2,107
  14. Anonymous
    Replies:
    16
    Views:
    4,795
  15. Anonymous
    Replies:
    4
    Views:
    3,456
  16. Anonymous
    Replies:
    18
    Views:
    3,432
  17. Anonymous
    Replies:
    8
    Views:
    4,637
  18. Anonymous
    Replies:
    10
    Views:
    6,899
  19. Anonymous
    Replies:
    57
    Views:
    36,475
  20. Anonymous
    Replies:
    5
    Views:
    2,575

Thread Display Options

Loading...